Dieter Hock

Title: Dieter Hock: Innovator in Peptide Research

Introduction

Dieter Hock is a notable inventor based in Neckarbischofsheim, Germany. He has made significant contributions to the field of peptide research, particularly in the development of innovative compounds for medical applications. With a total of 2 patents, his work has implications for various vaso- and renal-related disorders.

Latest Patents

Dieter Hock's latest patents include groundbreaking research on antibodies that bind peptides from the hPTH sequence (1-37). He has also developed phosphorylated derivatives of cardiodilatin/ANF peptides. These derivatives are described as compounds that comprise at least the amino acid sequence of alpha-hANaP. The compounds are formulated with a phosphate or thiophosphate group, and R can be NH₂ or a peptide fragment from the amino acid sequence of gamma-hANaP. Additionally, radio-labelled derivatives are possible. His patents also detail methods for the qualitative and/or quantitative determination of peptides containing the sequence of alpha-hANaP, as well as the use of these compounds as medicaments.

Career Highlights

Throughout his career, Dieter Hock has worked with several companies, including Haemopep Pharma GmbH and Pharma Bissendorf Peptide GmbH. His expertise in peptide research has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Dieter Hock has collaborated with notable professionals in his field, including Knut Adermann and Markus Magerlein. These collaborations have further enhanced his research and development efforts.

Conclusion

Dieter Hock's contributions to peptide research and his innovative patents highlight his role as a significant inventor in the medical field. His work continues to influence the development of new therapeutic options for various health conditions.